Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy

E-ISSN： 1873-5592|4|2|113-121

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.2, 2003-02, pp. : 113-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor Tyrosine Kinases and Anticancer Therapy

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1139-1149

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Targets for Anticancer Therapeutics

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1773-1781

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine kinases as targets in cancer therapy – successes and failures

By Traxler Peter

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 215-234

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine Kinases as Targets for Anti-Inflammatory Therapy

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite